Literature DB >> 23053331

[Diagnosis and therapy of pseudoexfoliation glaucoma].

A G M Jünemann1.   

Abstract

Pseudoexfoliation (PEX) glaucoma is the most frequent and most important type of secondary glaucoma, accounting for approximately 25% of open angle glaucoma worldwide and currently representing the most common identifiable cause of glaucoma overall. Due to high intraocular pressure levels, marked diurnal pressure fluctuations and spikes, and rapid optic nerve damage and visual field loss, PEX glaucoma represents a relatively severe and progressive type of glaucoma. Therefore, hard and fast lowering of intraocular pressure is necessary. Fixed combinations in medical therapy and early glaucoma surgery are recommended. When considering a surgical procedure (e.g. selective laser trabeculoplasty, bleb-dependent or bleb-independent surgery) the timing of cataract surgery plays a major role. Pathogenesis, clinical characteristics and therapeutic aspects of PEX glaucoma are described in the following article.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053331     DOI: 10.1007/s00347-012-2532-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  71 in total

Review 1.  Ab externo Schlemm's canal surgery: viscocanalostomy and canaloplasty.

Authors:  Matthias C Grieshaber
Journal:  Dev Ophthalmol       Date:  2012-04-17

2.  Diurnal variation of intraocular pressure and its correlation with retinal nerve fiber analysis in Turkish patients with exfoliation syndrome.

Authors:  Koray Gumus; Banu Bozkurt; Baris Sonmez; Murat Irkec; Mehmet Orhan; Osman Saracbasi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-02       Impact factor: 3.117

3.  Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma.

Authors:  Richard A Lewis; Kurt von Wolff; Manfred Tetz; Norbert Koerber; John R Kearney; Bradford J Shingleton; Thomas W Samuelson
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

4.  Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.

Authors:  Gennady Landa; Ayala Pollack; Rony Rachmiel; Amir Bukelman; Arie Marcovich; Miriam Zalish
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-08       Impact factor: 3.117

5.  A twenty-year follow-up study of trabeculectomy: risk factors and outcomes.

Authors:  John Landers; Keith Martin; Nicholas Sarkies; Rupert Bourne; Peter Watson
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

6.  Combined clear cornea phacoemulsification and trabecular aspiration in the treatment of pseudoexfoliative glaucoma associated with cataract.

Authors:  G T Georgopoulos; J Chalkiadakis; G Livir-Rallatos; P G Theodossiadis; G P Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-10       Impact factor: 3.117

7.  Pseudo-exfoliation, IOP and glaucoma.

Authors:  M Davanger; A Ringvold; S Blika
Journal:  Acta Ophthalmol (Copenh)       Date:  1991-10

8.  Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma.

Authors:  Stefan Bleich; Johannes Roedl; Nicolas Von Ahsen; Ursula Schlötzer-Schrehardt; Udo Reulbach; Georg Beck; Friedrich E Kruse; Gottfried O H Naumann; Johannes Kornhuber; Anselm G M Jünemann
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma.

Authors:  George G Koliakos; Christina D Befani; Dimitrios Mikropoulos; Nikolaos G Ziakas; Anastasios G P Konstas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-08       Impact factor: 3.117

10.  Factors associated with long-term progression or stability in exfoliation glaucoma.

Authors:  Anastasios G P Konstas; Gabor Hollo; Yuri S Astakhov; Miguel A Teus; Evgeny L Akopov; Jessica N Jenkins; William C Stewart
Journal:  Arch Ophthalmol       Date:  2004-01
View more
  2 in total

1.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma.

Authors:  Milena Pahlitzsch; Necip Torun; Carl Erb; Jeanette Bruenner; Anna Karina B Maier; Johannes Gonnermann; Eckart Bertelmann; Matthias K J Klamann
Journal:  Clin Ophthalmol       Date:  2015-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.